Coronary angiography and CMR images in the presence or absence of microvascular obstruction.

<p><b>a)</b> Coronary angiography images showing proximal occlusion of the left anterior descending artery, <b>b)</b> CMR demonstrating short axis T2 weighted imaging of myocardium at risk (early CMR), <b>c)</b> short axis late enhancement imaging (early CMR), and <b>d)</b> short axis late enhancement imaging (late CMR), in patients with (MVO +) or without (MVO -) microvascular obstruction. Early CMR was performed 1–4 days after primary PCI and late CMR was performed 4 months later.</p

Study flow - diagram of included patients.

<p>Study flow - diagram of included patients.</p

Myocardial salvage in patients with or without microvascular obstruction (MVO).

<p>Myocardial salvage, in patients with (MVO +) or without (MVO−) microvascular obstruction, assessed both by early and late CMR, respectively (percent, median values, and interquartile range).</p

Osteoprotegerin (OPG) levels in patients with stable coronary artery disease (CAD) before and after heparin administration.

<p>Blood samples were drawn from patients (n = 20) during elective coronary angiography. A venous sample was taken before angiography (<b>A</b>, median 72 min before heparin). Arterial samples were taken immediately after cannulation (<b>B</b>, 1 min before heparin), and at the end of the angiography procedure (<b>C</b>, 20 min after heparin). Data are presented as boxplots, with median (line), 25^th and 75^th percentile (box) and range (whiskers).</p

Baseline characteristics of the study population related to osteoprotegerin (OPG) levels measured at Day 1 (above or below median value).

<p>Baseline characteristics of the study population related to osteoprotegerin (OPG) levels measured at Day 1 (above or below median value).</p

Myocardial injury and function measured by CMR according to osteoprotegerin (OPG) values measured at Day 1.

<p>Myocardial injury and function measured by CMR according to osteoprotegerin (OPG) values measured at Day 1.</p

Temporal profile of osteoprotegerin (OPG) during the course of STEMI.

<p>OPG was measured in 255 patients with STEMI at the beginning and immediately after the PCI procedure, at Day 1 (median 14.7 hours after PCI), and at 4-month follow-up. Data are presented as median (boxes) with 25^th and 75^th percentile (whiskers). *p<0.001 for change in OPG levels from before PCI; **p<0.001 for both change in OPG levels from before PCI and from Day 1. <b>Inset:</b> OPG levels in patients treated with iPost or control.</p

Study flow diagram.

<p>Study flow diagram.</p

Osteoprotegerin (OPG) levels in patients with stable coronary artery disease (CAD) before and after heparin administration.

<p>Blood samples were drawn from patients (n = 20) during elective coronary angiography. A venous sample was taken before angiography (<b>A</b>, median 72 min before heparin). Arterial samples were taken immediately after cannulation (<b>B</b>, 1 min before heparin), and at the end of the angiography procedure (<b>C</b>, 20 min after heparin). Data are presented as boxplots, with median (line), 25^th and 75^th percentile (box) and range (whiskers).</p